Omnia SanaPlant Comparison
Greater Celandine vs Blessed Thistle
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Greater Celandine and Blessed Thistle: they share 8 indicated uses (arthritis / joint pain, bloating, cancer (anticancer research), …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Greater Celandine | Blessed Thistle | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Bloating | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Indigestion | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The biologically active and toxicologically important constituents.
Pharmacological Actions
Anti-inflammatory, antimicrobial and analgesic (preclinical)
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
Appetite stimulant for loss of appetite (approved use under German Commission E)
Bitter digestive / stomachic for indigestion and dyspepsia (stimulates saliva and gastric secretion)
Bitter digestive / stomachic for indigestion and dyspepsia (stimulates saliva and gastric secretion)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
inferred from anticancer action
Antispasmodic / choleretic bitter for upper-abdominal and biliary dyspepsia (indigestion, bloating, cramping) - oral use now restricted for safety
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from anti-inflammatory action
Appetite stimulant for loss of appetite (approved use under German Commission E)
inferred from anti-inflammatory action
inferred from anticancer action
Bitter digestive / stomachic for indigestion and dyspepsia (stimulates saliva and gastric secretion)
inferred from antimicrobial action
inferred from anti-inflammatory action
Galactagogue to support breast-milk supply (traditional; no valid clinical-trial evidence)
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
SERIOUS: oral greater celandine can cause acute idiosyncratic liver injury (hepatocellular hepatotoxicity with jaundice). Multiple reported cases - dozens of herb-induced liver injury reports in the literature, with continuing recent case reports - led regulators to restrict or suspend oral products. Do not take internally if you have any liver disease, and stop immediately and seek care at any sign of liver problems (jaundice, dark urine, upper-abdominal pain).
As a member of the daisy family (Asteraceae/ragweed), it can cause allergic reactions in sensitive people; high doses reportedly cause stomach cramps, nausea and vomiting.
Avoid during pregnancy because of a traditional uterine-stimulating reputation.
Although traditionally used to support milk supply, there is no scientifically valid clinical evidence for the galactagogue use.
External Ids
Botanical Description
Branching perennial herb with soft, brittle, hairy stems that exude a distinctive bright orange-yellow latex (sap) when cut or broken. The leaves are deeply lobed, pale bluish-green beneath, giving a delicate, almost fern-like appearance. Small, four-petalled, bright yellow flowers are borne in loose umbel-like clusters.[4]
Branching annual herb with a hairy, reddish, ridged stem and spiny, deeply lobed leaves with prominent pale veins. The flower heads are pale yellow, thistle-like, surrounded by a whorl of spiny, leaf-like bracts, giving the plant its 'spotted thistle' appearance.[4]
Habitat
Grows in shaded, nutrient-rich ground - hedgerows, walls, waste ground and woodland edges, often near old buildings; native to Europe and Western Asia and naturalised in North America.[4]
Grows on dry, sunny waste ground, roadsides and rocky slopes; native to the Mediterranean region and Western Asia and naturalised elsewhere as a garden escape.[4]
Harvesting
The flowering aerial parts are cut in spring to summer; the fresh orange latex is collected by breaking a stem or leaf as needed for topical (wart) use. Given the documented hepatotoxicity of oral preparations, harvesting for internal use is not recommended.[4]
The flowering aerial parts are cut as the plant comes into flower, in summer, and dried in a warm, shaded, airy place to preserve the bitter principle cnicin.[4]
Traditional Uses
Greater celandine has a long European folk history, reflected in its name 'tetterwort', as a topical remedy for warts and skin blemishes (the fresh orange latex dabbed directly on), and internally as a bitter choleretic digestive remedy for biliary and upper-abdominal dyspepsia - though oral use is now medically restricted because of documented liver injury.[4]
Blessed thistle has a long European folk reputation as a bitter digestive tonic for loss of appetite and dyspepsia (an approved use under German Commission E) and, more anecdotally, as a traditional galactagogue to support breast-milk supply, though robust clinical evidence for the latter is lacking.[4, 11]
Preparations
Fresh orange latex from a broken stem dabbed directly onto warts, the classic external folk use; kept well away from eyes, mucous membranes and broken skin.
Historically taken as an infusion or tincture for biliary dyspepsia, but oral use is now restricted in several jurisdictions due to hepatotoxicity risk and should only be considered under professional supervision, if at all.
Dried flowering herb infused briefly in hot water as a bitter digestive tea, taken before meals.
Dosage
Because of a documented risk of acute liver injury, no internal dose is given here; oral use should be avoided, especially by anyone with liver disease, and any sign of jaundice, dark urine or upper-abdominal pain warrants immediate medical attention. Educational reference only, not a prescription.
Traditional herbal references suggest around 1-2 g of dried herb per cup, taken before meals, up to three times daily. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Li, X.L., Sun, Y.P., Wang, M., Wang, Z.B. and Kuang, H.X (2024) 'Alkaloids in Chelidonium majus L.: a review of its phytochemistry, pharmacology and toxicology', Frontiers in Pharmacology, 15, pp. 1440979. doi:10.3389/fphar.2024.1440979 Traditional / reference
https://doi.org/10.3389/fphar.2024.1440979 - Koriem, K.M.M., Arbid, M.S. and Asaad, G.F (2012) 'Chelidonium majus leaves methanol extract and its chelidonine alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats', Journal of Natural Medicines, 67(1), pp. 159-167. doi:10.1007/s11418-012-0667-6 Preclinical
https://doi.org/10.1007/s11418-012-0667-6 - Nawrot, R (2017) 'Defense-related Proteins from Chelidonium majus L. as Important Components of its Latex', Current Protein & Peptide Science, 18(8), pp. 864-880. doi:10.2174/1389203718666170406124013 Traditional / reference
https://doi.org/10.2174/1389203718666170406124013 - Gilca, M., Gaman, L., Panait, E., Stoian, I. and Atanasiu, V (2010) 'Chelidonium majus - an integrative review: traditional knowledge versus modern findings', Forschende Komplementarmedizin. doi:10.1159/000321397 Traditional / reference
https://doi.org/10.1159/000321397 - Popovic, A., Deljanin, M., Popovic, S., Todorovic, D., Djurdjevic, P., Matic, S., Stankovic, M., Avramovic, D. and Baskic, D (2021) 'Chelidonium majus crude extract induces activation of peripheral blood mononuclear cells and enhances their cytotoxic effect toward HeLa cells', International Journal of Environmental Health Research, 32(7), pp. 1554-1566. doi:10.1080/09603123.2021.1897534 Preclinical
https://doi.org/10.1080/09603123.2021.1897534 - Shen, L., Lee, S.A., Joo, J.C., Hong, E., Cui, Z.Y., Jo, E., Park, S.J. and Jang, H.J (2022) 'Chelidonium majus induces apoptosis of human ovarian cancer cells via ATF3-mediated regulation of Foxo3a by Tip60', Journal of Microbiology and Biotechnology, 32(4), pp. 493-503. doi:10.4014/jmb.2109.09030 Preclinical
https://doi.org/10.4014/jmb.2109.09030 - Deljanin, M., Nikolic, M., Baskic, D., Todorovic, D., Djurdjevic, P., Zaric, M., Stankovic, M., Todorovic, M., Avramovic, D. and Popovic, S (2016) 'Chelidonium majus crude extract inhibits migration and induces cell cycle arrest and apoptosis in tumor cell lines', Journal of Ethnopharmacology, 190, pp. 362-371. doi:10.1016/j.jep.2016.06.056 Preclinical
https://doi.org/10.1016/j.jep.2016.06.056 - Warowicka, A., Qasem, B., Dera-Szymanowska, A., Wolun-Cholewa, M., Florczak, P., Horst, N., Napierala, M., Szymanowski, K., Popenda, L., Bartkowiak, G., Florek, E., Gozdzicka-Jozefiak, A. and Mlynarz, P (2021) 'Effect of protoberberine-rich fraction of Chelidonium majus L. on endometriosis regression', Pharmaceutics, 13(7), pp. 931. doi:10.3390/pharmaceutics13070931 Preclinical
https://doi.org/10.3390/pharmaceutics13070931 - Kadan, G., Gozler, T. and Hesse, M (1992) '(+)-Norchelidonine from Chelidonium majus', Planta Medica, 58(5), pp. 477. doi:10.1055/s-2006-961523 Preclinical
https://doi.org/10.1055/s-2006-961523 - Musidlak, O., Warowicka, A., Broniarczyk, J., Adamczyk, D., Gozdzicka-Jozefiak, A. and Nawrot, R (2022) 'The activity of Chelidonium majus L. latex and its components on HPV reveal insights into the antiviral molecular mechanism', International Journal of Molecular Sciences, 23(16), pp. 9241. doi:10.3390/ijms23169241 Preclinical
https://doi.org/10.3390/ijms23169241 - Zhang, W., You, C., Wang, C., Fan, L., Wang, Y., Su, Y., Deng, Z. and Du, S (2014) 'One new alkaloid from Chelidonium majus L', Natural Product Research, 28(21), pp. 1873-1878. doi:10.1080/14786419.2014.953497 Preclinical
https://doi.org/10.1080/14786419.2014.953497 - Capistrano I, R., Wouters, A., Lardon, F., Gravekamp, C., Apers, S. and Pieters, L (2015) 'In vitro and in vivo investigations on the antitumour activity of Chelidonium majus', Phytomedicine, 22(14), pp. 1279-1287. doi:10.1016/j.phymed.2015.10.013 Preclinical
https://doi.org/10.1016/j.phymed.2015.10.013 - Teschke, R., Frenzel, C., Glass, X., Schulze, J. and Eickhoff, A (2012) 'Greater Celandine hepatotoxicity: a clinical review', Annals of Hepatology. doi:10.1016/s1665-2681(19)31408-5 Clinical study
https://doi.org/10.1016/s1665-2681(19)31408-5 - Ciornolutchii, V., Ismaiel, A., Sabo, C.M., Al Hajjar, N., Seicean, A. and Dumitrascu, D.L (2024) 'A Hidden Cause of Hypertransaminasemia: Liver Toxicity Caused by Chelidonium Majus L. Report of Two Cases of Herb-Induced Liver Injury and Literature Review', American Journal of Therapeutics, 31(4), pp. e382--e387. doi:10.1097/MJT.0000000000001708 Clinical study
https://doi.org/10.1097/MJT.0000000000001708
- Rezig, K., Benkaci-Ali, F., Foucaunier, M.L., Laurent, S. et al (2023) 'HPLC/ESI-MS Characterization of Phenolic Compounds from Cnicus benedictus L. Roots: A Study of Antioxidant, Antibacterial, Anti-Inflammatory, and Anti-Alzheimer's Activity', Chemistry & Biodiversity, 21(1), pp. e202300724. doi:10.1002/cbdv.202300724 Preclinical
https://doi.org/10.1002/cbdv.202300724 - Ahmadimoghaddam, D., Sadeghian, R., Ranjbar, A., Izadidastenaei, Z. and Mohammadi, S (2020) 'Antinociceptive activity of Cnicus benedictus L. leaf extract: a mechanistic evaluation', Research in Pharmaceutical Sciences, 15(5), pp. 463-472. doi:10.4103/1735-5362.297849 Preclinical
https://doi.org/10.4103/1735-5362.297849 - Zhang, J., Shen, S., Zhu, S., Jia, F. et al (2024) 'Cnicus benedictus extract-loaded electrospun gelatin wound dressing for treating diabetic wounds: An in vitro and in vivo study', Journal of Applied Biomaterials & Functional Materials, 22, pp. 22808000241245298. doi:10.1177/22808000241245298 Preclinical
https://doi.org/10.1177/22808000241245298 - Zietal, K., Mirowska-Guzel, D., Nowaczyk, A. and Blecharz-Klin, K (2024) 'Cnicus benedictus: Folk Medicinal Uses, Biological Activities, and In Silico Screening of Main Phytochemical Constituents', Planta Medica. doi:10.1055/a-2401-6049 Traditional / reference
https://doi.org/10.1055/a-2401-6049 - Jalil, D.M., Al-Mahdawi, T.T., Jameel, M.G. and Talal, M (2024) 'In Vitro Evaluate the Antiproliferative Impact of Cnicus Benedictus L. Leaves Methanolic Extract on Cervical Cancer', Asian Pacific Journal of Cancer Prevention, 25(10), pp. 3643-3649. doi:10.31557/APJCP.2024.25.10.3643 Preclinical
https://doi.org/10.31557/APJCP.2024.25.10.3643 - Peng, Y., Jian, Y., Zulfiqar, A., Li, B., Zhang, K., Long, F., Peng, C., Cai, X., Khan, I.A. and Wang, W (2017) 'Two new sesquiterpene lactone glycosides from Cnicus benedictus', Natural Product Research, 31(19), pp. 2211-2217. doi:10.1080/14786419.2017.1295239 Preclinical
https://doi.org/10.1080/14786419.2017.1295239 - Paun, G., Neagu, E., Moroeanu, V., Albu, C., Savin, S. and Lucian Radu, G (2019) 'Chemical and Bioactivity Evaluation of Cnicus benedictus and Eryngium planum Polyphenolic-Rich Extracts', BioMed Research International, 2019, pp. 3692605. doi:10.1155/2019/3692605 Preclinical
https://doi.org/10.1155/2019/3692605 - Gobrecht, P., Gebel, J., Leibinger, M., Zeitler, C., Chen, Z., Grundemann, D. and Fischer, D (2024) 'Cnicin promotes functional nerve regeneration', Phytomedicine, 129, pp. 155641. doi:10.1016/j.phymed.2024.155641 Preclinical
https://doi.org/10.1016/j.phymed.2024.155641 - Avula, B., Katragunta, K., Wang, Y.H., Ali, Z. and Khan, I.A (2022) 'Simultaneous determination and characterization of flavonoids, sesquiterpene lactone, and other phenolics from Centaurea benedicta and dietary supplements using UHPLC-PDA-MS and LC-DAD-QToF', Journal of Pharmaceutical and Biomedical Analysis, 216, pp. 114806. doi:10.1016/j.jpba.2022.114806 Preclinical
https://doi.org/10.1016/j.jpba.2022.114806 - Paun, G., Neagu, E., Albu, C. and Radu, G.L (2015) 'Inhibitory potential of some Romanian medicinal plants against enzymes linked to neurodegenerative diseases and their antioxidant activity', Pharmacognosy Magazine, 11(Suppl 1), pp. S110-S116. doi:10.4103/0973-1296.157709 Preclinical
https://doi.org/10.4103/0973-1296.157709 - Drugs.com (n.d.) 'Blessed Thistle Uses, Benefits & Dosage'. Available at: https://www.drugs.com/npp/blessed-thistle.html Traditional / reference
https://www.drugs.com/npp/blessed-thistle.html - Drugs and Lactation Database (LactMed) (2021) 'Blessed Thistle'. Available at: https://www.ncbi.nlm.nih.gov/books/NBK501775/ Traditional / reference
https://www.ncbi.nlm.nih.gov/books/NBK501775/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.